|
COMMERCE BUSINESS DAILY ISSUE OF MARCH 16,1998 PSA#2052National Institutes of Health, National Institute of Allergy and
Infectious Diseases, Contract Management Branch, Solar Bldg., Room
3C07, 6003 Executive Blvd. MSC 7610, Bethesda, MD 20892-7610 A -- CANDIDATE HIV RECOMBINANT VACCINES FOR CLINICAL TRIALS SOL n/a
DUE 032098 POC Frederick R. Vogel, (301) 435-3747, Fax (301) 402-3684,
E-Mail fvlv@nih.gov The Division of AIDS (DAIDS), NIAID, NIH is
conducting a market survey to determine the availability and capability
of developers of two HIV vaccine reagents. These are: 1) an intact
virion HIV containing an NSI env protein, that is genetically incapable
of replication (i.e., a "pseudovirion"). 2) HIV env proteins from
primary isolates (NSI or dual-tropic) produced in mammalian expression
vectors. Since these products will be considered for Phase I clinical
trials alone and in combination with other vaccine products and may
eventually be considered for larger-scale clinical trials, these
products must be manufactured under cGMP conditions. To be considered,
developers must: (1) have an existing relationship with (or be) a
manufacturer with experience in producing HIV candidate vaccines
meeting FDA standards for use in human studies involving healthy
volunteers; (2) have experience with recombinant protein HIV vaccines;
and (3) be willing to supply the candidate vaccine components for use
in nonhuman primate studies as well as in clinical trials in
combination with other vaccines. Interested firms must document their
past experience and technical expertise in each of the above areas.
This is not a Request for Proposal (RFP). NO RFP is available and DAIDS
is not committed to award a subcontract pursuant to this announcement.
Interested firms should furnish 5 copies of their capability
information addressing the three (3) areas cited above, no later than
4:30 p.m. local time on March 31, 1998 to Frederick R. Vogel, Vaccine
and Prevention Research Program, DAIDS/NIAID, 6003 Executive Blvd., Rm.
2A-02, Rockville, MD 20852, Tel. (301) 435-3747, Fax. (301) 402-3684,
E-mail fv1v@nih.gov. (0071) Loren Data Corp. http://www.ld.com (SYN# 0020 19980316\A-0020.SOL)
A - Research and Development Index Page
|
|